To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Oral anticoagulants/LMW heparins provide comparable safety in antithrombotic prophylaxis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
February 2017

Oral anticoagulants/LMW heparins provide comparable safety in antithrombotic prophylaxis

Vol: 6| Issue: 2| Number:13| ISSN#: 2564-2537
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A

Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis

Semin Thromb Hemost. 2016 Feb;42(1):42-54

Contributing Authors:
N Riva F Dentali ET Permunian W Ageno

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

25 randomized controlled trials (RCTs) investigating the safety of direct oral anticoagulants and low molecular weight heparin/fondaparinux in antithrombotic prophylaxis during total hip replacement, total knee replacement, and hip fracture surgery were included. This meta-analysis was conducted in order to determine if direct oral anticoagulants, in addition to the more convenient oral administra...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue